Antineoplastics: Epstein-Barr virus lymphoproliferative disease in a child: case report

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1193, 2008-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Azathioprine/ciclosporin: Epstein-Barr virus-related lymphoproliferative disorder in a child: case report

Reactions Weekly, Vol. 1, Iss. 1192, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Ciclosporin: Epstein-Barr virus-associated lymphoproliferative disorder: case report

Reactions Weekly, Vol. 1, Iss. 1047, 2005-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Infliximab: Epstein-Barr virus associated lymphoproliferative disorder: case report

Reactions Weekly, Vol. 1, Iss. 1283, 2010-01 ,pp. : 53-54

Adis International

Access to resources Recommend Favorite

Antithymocyte globulin/cyclophosphamide/muromonab CD3: Epstein-Barr virus lymphoproliferative disease: case report

Reactions Weekly, Vol. 1, Iss. 1180, 2007-01 ,pp. : 4-5

Adis International

Access to resources Recommend Favorite

Immunosuppressants: Epstein-Barr virus infection in a child: case report

Reactions Weekly, Vol. 1, Iss. 1210, 2008-01 ,pp. : 19-20

Adis International

Access to resources Recommend Favorite